Soluble guanylate cyclase: a potential therapeutic target for heart failure
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Soluble guanylate cyclase: a potential therapeutic target for heart failure
Authors
Keywords
Heart failure, Soluble guanylate cyclase, Cyclic guanosine monophosphate, Treatment, Pathophysiology
Journal
HEART FAILURE REVIEWS
Volume 18, Issue 2, Pages 123-134
Publisher
Springer Nature
Online
2012-05-23
DOI
10.1007/s10741-012-9323-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Factors associated with improvement in ejection fraction in clinical practice among patients with heart failure: Findings from IMPROVE HF
- (2011) Jane E. Wilcox et al. AMERICAN HEART JOURNAL
- Measuring oxidative burden and predicting pharmacological response in coronary artery disease patients with a novel direct activator of haem-free/oxidised sGC
- (2011) Ingo Ahrens et al. ATHEROSCLEROSIS
- Soluble Guanylate Cyclase as an Emerging Therapeutic Target in Cardiopulmonary Disease
- (2011) Johannes-Peter Stasch et al. CIRCULATION
- Improving Postdischarge Outcomes in Patients Hospitalized for Acute Heart Failure Syndromes
- (2011) Mihai Gheorghiade JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Treatment of acute decompensated heart failure with the soluble guanylate cyclase activator cinaciguat: The COMPOSE program – three randomized, controlled, phase IIb studies
- (2011) Mihai Gheorghiade et al. JOURNAL OF CARDIAC FAILURE
- Additional stimulation of sGC on top of standard treatment with ARB`s may offer a new therapeutic approach for the treatment of diabetic nephropathy resistant to ARB treatment alone
- (2011) Markus Alter et al. BMC Pharmacology & Toxicology
- Cell Death in the Pathogenesis of Heart Disease: Mechanisms and Significance
- (2010) Russell S. Whelan et al. Annual Review of Physiology
- Cardiorenal Syndrome
- (2010) Jeremy S. Bock et al. CIRCULATION
- Is oxidative stress a therapeutic target in cardiovascular disease?
- (2010) Thomas Münzel et al. EUROPEAN HEART JOURNAL
- Structure of Cinaciguat (BAY 58–2667) Bound toNostocH-NOX Domain Reveals Insights into Heme-mimetic Activation of the Soluble Guanylyl Cyclase
- (2010) Faye Martin et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Nitric oxide-independent stimulation of soluble guanylate cyclase reduces organ damage in experimental low-renin and high-renin models
- (2010) Yuliya Sharkovska et al. JOURNAL OF HYPERTENSION
- Guanylyl cyclase activator ataciguat improves vascular function and reduces platelet activation in heart failure
- (2010) Andreas Schäfer et al. PHARMACOLOGICAL RESEARCH
- Endothelial dysfunction and vascular disease
- (2009) P. M. Vanhoutte et al. Acta Physiologica
- Phase III clinical trial end points in acute heart failure syndromes: A virtual roundtable with the acute heart failure syndromes international working group
- (2009) Mihai Gheorghiade et al. AMERICAN HEART JOURNAL
- Soluble Guanylate Cyclase Agonists Inhibit Expression and Procoagulant Activity of Tissue Factor
- (2009) Mikhail A. Sovershaev et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Discovery of Riociguat (BAY 63-2521): A Potent, Oral Stimulator of Soluble Guanylate Cyclase for the Treatment of Pulmonary Hypertension
- (2009) Joachim Mittendorf et al. ChemMedChem
- Cinaciguat (BAY 58–2667) Improves Cardiopulmonary Hemodynamics in Patients With Acute Decompensated Heart Failure
- (2009) Harald Lapp et al. CIRCULATION
- Heart Disease and Stroke Statistics—2010 Update
- (2009) et al. CIRCULATION
- Pressure-independent effects of pharmacological stimulation of soluble guanylate cyclase on fibrosis in pressure-overloaded rat heart
- (2009) Hiroyuki Masuyama et al. HYPERTENSION RESEARCH
- Acute hemodynamic response to single oral doses of BAY 60-4552, a soluble guanylate cyclase stimulator, in patients with biventricular heart failure
- (2009) Veselin Mitrovic et al. BMC Pharmacology & Toxicology
- NO-insensitive sGCbeta1 H105F knockin mice: if NO has no place to go
- (2009) Robrecht Thoonen et al. BMC Pharmacology & Toxicology
- Cardioprotective effects in aged spontaneously hypertensive rats due to chronic stimulation/activation of sGC without hypotension
- (2009) Emma S Jones et al. BMC Pharmacology & Toxicology
- Gender-specific hypertension and responsiveness to nitric oxide in sGCα1 knockout mice
- (2008) Emmanuel S. Buys et al. CARDIOVASCULAR RESEARCH
- Urinary Biomarkers for Sensitive and Specific Detection of Acute Kidney Injury in Humans
- (2008) Vishal S. Vaidya et al. CTS-Clinical and Translational Science
- NO-independent activation of soluble guanylate cyclase prevents disease progression in rats with 5/6 nephrectomy
- (2006) Philipp Kalk et al. BRITISH JOURNAL OF PHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started